메뉴 건너뛰기




Volumn 57, Issue 3, 2013, Pages 1136-1143

Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TECOVIRIMAT;

EID: 84874046536     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00959-12     Document Type: Article
Times cited : (21)

References (30)
  • 1
    • 0018967338 scopus 로고
    • The global eradication of smallpox
    • Fenner F. 1980. The global eradication of smallpox. Med. J. Aust. 1:455.
    • (1980) Med. J. Aust. , vol.1 , pp. 455
    • Fenner, F.1
  • 3
    • 84874044394 scopus 로고
    • London, United Kingdom, A. Churchill Ltd.
    • Dixon CW. 1962. Smallpox. J. & A. Churchill Ltd., London, United Kingdom.
    • (1962) Smallpox. J.
    • Dixon, C.W.1
  • 4
    • 0036631801 scopus 로고    scopus 로고
    • Studies in smallpox and vaccination. 1913
    • Hanna W, Baxby D. 2002. Studies in smallpox and vaccination. 1913. Rev. Med. Virol. 12:201-209.
    • (2002) Rev. Med. Virol , vol.12 , pp. 201-209
    • Hanna, W.1    Baxby, D.2
  • 6
    • 43649089767 scopus 로고    scopus 로고
    • Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model
    • Nalca A, Hatkin JM, Garza NL, Nichols DK, Norris SW, Hruby DE, Jordan R. 2008. Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model. Antivir. Res. 79:121-127.
    • (2008) Antivir. Res. , vol.79 , pp. 121-127
    • Nalca, A.1    Hatkin, J.M.2    Garza, N.L.3    Nichols, D.K.4    Norris, S.W.5    Hruby, D.E.6    Jordan, R.7
  • 16
    • 37849005004 scopus 로고    scopus 로고
    • Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge
    • Marriott KA, Parkinson CV, Morefield SI, Davenport R, Nichols R, Monath TP. 2008. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. Vaccine 26:581-588.
    • (2008) Vaccine , vol.26 , pp. 581-588
    • Marriott, K.A.1    Parkinson, C.V.2    Morefield, S.I.3    Davenport, R.4    Nichols, R.5    Monath, T.P.6
  • 20
    • 0035216180 scopus 로고    scopus 로고
    • Ways to fit a PK model with some data below the quantification limit
    • Beal SL. 2001. Ways to fit a PK model with some data below the quantification limit. J. Pharmacokinet. Pharmacodyn. 28:481-504.
    • (2001) J. Pharmacokinet. Pharmacodyn , vol.28 , pp. 481-504
    • Beal, S.L.1
  • 24
    • 0029951033 scopus 로고    scopus 로고
    • A size standard for pharmacokinetics
    • Holford NH. 1996. A size standard for pharmacokinetics. Clin. Pharmacokinet. 30:329 -332.
    • (1996) Clin. Pharmacokinet , vol.30 , pp. 329-332
    • Holford, N.H.1
  • 25
    • 70449647008 scopus 로고
    • Proportional hazards tests and diagnostics based on weighted residuals
    • Grambsch PM, Therneau TM. 1994. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515-526.
    • (1994) Biometrika , vol.81 , pp. 515-526
    • Grambsch, P.M.1    Therneau, T.M.2
  • 27
    • 0028792083 scopus 로고
    • First-time-in-human dose selection: Allometric thoughts and perspectives
    • Boxenbaum H, DiLea C. 1995. First-time-in-human dose selection: allometric thoughts and perspectives. J. Clin. Pharmacol. 35:957-966.
    • (1995) J. Clin. Pharmacol , vol.35 , pp. 957-966
    • Boxenbaum, H.1    Dilea, C.2
  • 28
    • 84866079822 scopus 로고    scopus 로고
    • FDA experience with medical countermeasures under the animal rule
    • doi:10.1155/2012/507571
    • Aebersold P. 2012. FDA experience with medical countermeasures under the animal rule. Adv. Prev. Med. 2012:507571. doi:10.1155/2012/507571.
    • (2012) Adv. Prev. Med. , vol.2012 , pp. 507571
    • Aebersold, P.1
  • 30
    • 69449088646 scopus 로고    scopus 로고
    • The animal rule and emerging infections: The role of clinical pharmacology in determining an effective dose
    • Bergman KL. 2009. The animal rule and emerging infections: the role of clinical pharmacology in determining an effective dose. Clin. Pharmacol. Ther. 86:328 -331.
    • (2009) Clin. Pharmacol. Ther , vol.86 , pp. 328-331
    • Bergman, K.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.